Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Former NBA player Jason Collins has died after a battle with brain cancer. His husband, film producer Brunson Green, was a constant source ...

Wildlife thrives in Chernobyl's exclusion zone. Grey wolves there show remarkable genetic changes. These wolves have developed resistance t...

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

Bestselling author Colleen Hoover, recognized for It Ends With Us, confirmed her cancer diagnosis and shared updates on her recovery. Diagn...

The Indian Institute of Technology (IIT), Madras has set up a Centre of Excellence to develop biomarkers for early detection of pancreatic ...

At the Christie hospital in Manchester, medical professionals are currently overseeing approximately 30 clinical trials. Encouragingly, the...

The company has achieved a key milestone for its novel MALT1 (Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1) inhibitor...

Natco Pharma has launched a novel fixed-dose combination of Trifluridine and Tipiracil, used to treat advanced colorectal and gastric cance...

The drug, called tisotumab vedotin (TV), releases a toxic substance to kill cancer cells from within.

Singapore, Sep 2 (IANS) Singaporean researchers have harnessed the power of artificial intelligence (AI) to successfully treat a patient wi...

A next-generation cell-based immunotherapy may offer new hope in the fight against the most aggressive form of brain cancer.

Biotechnology firm Transgene Biotek has received patent in the US for its novel molecule to be developed for treatment of liver cancer

The study opens the door for therapies which suppress the gene and for screening that would pick up the risk early.

Treatment of brain tumours is particularly challenging because regulatory T-cells accumulate in brain tumours and suppress an immune attack.

The Advanced Centre for Treatment Research and Education in Cancer (ACTREC) has installed dual purpose hi-tech TomoTherapy system, a first ...

Biotech firm Panacea Biotec on Thursday said it is planning to foray into oncology segment.